PRESS RELEASE published on 01/28/2025 at 07:30, 1 year ago Nicox : Présentation Scientifique et Participation aux Congrès du premier semestre 2025 Nicox annonce sa participation à des congrès internationaux en ophtalmologie et finance au premier semestre 2025, y compris l'AGS 2025 Congrès Annuel Finance Ophtalmologie Congrès Nicox AGS 2025
PRESS RELEASE published on 01/28/2025 at 07:30, 1 year ago Nicox Announces Scientific Presentation and Conference Attendance in H1 2025 Nicox to present at AGS 2025 Annual Meeting and attend key ophthalmology and financial conferences in H1 2025. Dr. Robert Fechtner to present NCX 470 analysis at AGS 2025 Conference Ophthalmology Nicox NCX 470 AGS 2025
BRIEF published on 01/22/2025 at 07:35, 1 year ago Nicox maintient son éligibilité au PEA-PME PEA-PME Investissement Euronext Ophtalmologie Nicox
BRIEF published on 01/22/2025 at 07:35, 1 year ago Nicox maintains its eligibility for the PEA-PME PEA-PME Euronext Investment Ophthalmology Nicox
PRESS RELEASE published on 01/22/2025 at 07:30, 1 year ago Nicox confirme son éligibilité au PEA-PME Nicox confirme son éligibilité au PEA-PME pour les 12 prochains mois, ouvrant la voie à l'investissement dans les petites et moyennes valeurs en ophtalmologie. Pour plus d'informations, consultez www.nicox.com PEA-PME Investissement Éligibilité Ophtalmologie Nicox
BRIEF published on 01/21/2025 at 07:35, 1 year ago Nicox : Résumé financier et activités du quatrième trimestre 2024 Résultats Financiers Trésorerie Nicox NCX 470 Quatrième Trimestre 2024
BRIEF published on 01/21/2025 at 07:35, 1 year ago Nicox: Fourth Quarter 2024 Financial and Business Summary Financial Results Treasury Nicox NCX 470 Fourth Quarter 2024
PRESS RELEASE published on 01/21/2025 at 07:30, 1 year ago Nicox : Point d’activité et résumé financier du quatrième trimestre 2024 Nicox annonce les résultats financiers du quatrième trimestre 2024, avec recrutement du dernier patient pour NCX 470 Denali et revenu de 13,7M€, trésorerie de 10,7M€. Prévisions et stratégies pour 2025 Résultats Financiers Stratégie 2025 Trimestre 2024 Nicox NCX 470 Denali
PRESS RELEASE published on 01/21/2025 at 07:30, 1 year ago Nicox Provides Business Update and Fourth Quarter 2024 Financial Highlights Nicox provides Q4 2024 financial highlights, including €13.7 million revenue and €10.7 million cash. Final patient enrolled in NCX 470 trial, with results expected in Q3 2025 Financial Highlights Nicox Q4 2024 Q3 2025 NCX 470 Trial
BRIEF published on 12/04/2024 at 07:35, 1 year 2 months ago Nicox's ZERVIATE Reaches Chinese Market Through Ocumension Partnership Ophthalmology Nicox ZERVIATE Ocumension China Market
Published on 02/10/2026 at 13:30, 17 minutes ago Revival Gold Intercepts 1.0 g/t Gold Over 30 Meters and Extends Mineralization at Mercur Project in Utah
Published on 02/10/2026 at 13:30, 17 minutes ago Metallic Minerals Provides Keno Silver Project Update and Details 2026 Exploration Plans
Published on 02/10/2026 at 13:00, 47 minutes ago Kalo Gold Advances 2026 Target Development at Vatu Aurum; Lidar and Orthophotography Completed; Airborne Geophysics Planned for February
Published on 02/10/2026 at 13:00, 47 minutes ago NOA Lithium Announces Additional Warrant Exercises for $818,000
Published on 02/10/2026 at 13:00, 47 minutes ago Neural Cloud Retains Commission Wolf to Accelerate U.S. Commercial Expansion
Published on 02/10/2026 at 13:35, 11 minutes ago Bernd Spalt fulfils current contract – but does not seek extension
Published on 02/10/2026 at 13:15, 32 minutes ago SCOPE’s Ultra-Luxury Residential Performance Underscores Strong Investor Confidence in Thailand’s Prime Market
Published on 02/10/2026 at 13:08, 38 minutes ago Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/10/2026 at 13:05, 42 minutes ago Commerzbank exceeds profit target and launches further share buyback of up to €540m – dividend for 2025 to be €1.10 per share
Published on 02/10/2026 at 13:03, 43 minutes ago EQS-Adhoc: Commerzbank Aktiengesellschaft: Commerzbank decides to implement a further share buyback
Published on 02/09/2026 at 18:00, 19 hours 47 minutes ago LANSON-BCC : Déclaration du nombre total des droits de vote et du nombre d’actions au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago Declaration of voting rights at the end of January 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago DAMARTEX / Droits de vote bruts et réels au 31 janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago Déclaration des droits de vote à fin janvier 2026
Published on 02/09/2026 at 17:45, 20 hours 2 minutes ago Déclaration des droits de vote à fin janvier 2026
